By Robert G. Marshall ( bio - articles - email ) | Apr 22, 2021 In July 2020, citing the Covid-19 emergency, a federal District Court judge unilaterally suspended the Food and Drug Administration (FDA) requirement that women seeking chemical abortions were required to appear in person at a hospital, clinic, or medical establishment to personally pick up the lethal drugs and sign a disclosure form. The Trump Administration challenged that federal District Court and on January 12, 2021, the U. S. Supreme Court overruled the federal District Court stating that federal courts, “owe significant deference to the politically accountable entities with the background, competence, and expertise to assess public health.” The effect of the ruling resulting from the Trump Administration’s challenge was that abortion pills could not be mailed but had to be given in person.